
ALNY
Healthcare · Biotechnology · $22.11B market cap
$165.04+8.39 (+5.4%)Nov 13, 4:04 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -13.0% over 90 days · 30-day revisions 2 up, 9 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | Before the open | 1.46 | 15.72 | +976.7% |
| Jul 30, 2026 | Before the open | 1.44 | 1.21 | -16.0% |
| Apr 30, 2026 | Before the open | 1.47 | 1.99 | +35.4% |
| Feb 12, 2026 | Before the open | 1.50 | 1.25 | -16.7% |
| Oct 30, 2025 | Before the open | 1.75 | 2.90 | +65.7% |
| Jul 31, 2025 | Before the open | 0.15 | 0.32 | +113.3% |
| May 1, 2025 | Before the open | -0.37 | -0.01 | +97.3% |
| Feb 13, 2025 | Before the open | -0.14 | 0.06 | +142.9% |
| Oct 31, 2024 | Before the open | -0.39 | -0.50 | -28.2% |
| Aug 1, 2024 | Before the open | -0.69 | 0.56 | +181.2% |
| May 2, 2024 | Before the open | -0.63 | -0.16 | +74.6% |
| Feb 15, 2024 | Before the open | -0.77 | -0.77 | 0.0% |
| Nov 2, 2023 | Before the open | -0.96 | 1.74 |
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and hATTR amyloidosis; Leqvio for hypercholesterolemia; Qfitlia for hemophilia A or B; GIVLAARI for acute hepatic porphyria;…
| +281.3% |
| Aug 3, 2023 | Before the open | -1.34 | -1.62 | -20.9% |
| May 4, 2023 | Before the open | -1.43 | -1.06 | +25.9% |
| Feb 23, 2023 | Before the open | -1.90 | -1.68 | +11.6% |
| Oct 27, 2022 | Before the open | -1.38 | -1.58 | -14.5% |
| Jul 28, 2022 | Before the open | -1.36 | -2.03 | -49.3% |
| Apr 28, 2022 | Before the open | -1.46 | -1.49 | -2.1% |
| Feb 10, 2022 | Before the open | -1.26 | -1.69 | -34.1% |
| Oct 28, 2021 | Before the open | -1.24 | -1.51 | -21.8% |
| Aug 3, 2021 | Before the open | -1.28 | -1.30 | -1.6% |
| Apr 29, 2021 | Before the open | -1.40 | -1.64 | -17.1% |
| Feb 11, 2021 | Before the open | -1.38 | -1.60 | -15.9% |
| Nov 5, 2020 | Before the open | -1.34 | -1.58 | -17.9% |
| Aug 6, 2020 | Before the open | -1.40 | -1.67 | -19.3% |
| May 6, 2020 | Before the open | -1.51 | -1.52 | -0.7% |
| Feb 6, 2020 | Before the open | -1.92 | -1.98 | -3.1% |
| Oct 31, 2019 | Before the open | -1.83 | -1.50 | +18.0% |
| Aug 6, 2019 | Before the open | -1.85 | -1.83 | +1.1% |
| May 1, 2019 | Before the open | -1.80 | -1.42 | +21.1% |
| Feb 7, 2019 | After the close | -1.93 | -1.82 | +5.7% |
| Nov 7, 2018 | Before the open | -1.79 | -1.56 | +12.8% |
| Aug 2, 2018 | Before the open | -1.71 | -1.83 | -7.0% |
| May 3, 2018 | After the close | -1.51 | -1.41 | +6.6% |
| Feb 8, 2018 | Before the open | -1.36 | -1.48 | -8.8% |